Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dougald Monroe

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Blood|June 20, 2020
EPCR knockout: inflaming the discussionDougald Monroe, Maureane Hoffman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2009
What is wrong with the allosteric disulfide bond hypothesis?Ronald R Bach, Dougald Monroe
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2013
Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targetsMarshall Mazepa, Maureane Hoffman, Dougald Monroe
Blood|January 16, 2014
FVIIa as used pharmacologically is not TF dependent in hemophilia B miceDengmin Feng, Herbert Whinna, Dougald Monroe, et al.
Plos Computational Biology|November 15, 2024
A new look at TFPI inhibition of factor X activationFabian Santiago, Amandeep Kaur, Shannon Bride, et al.
Research and Practice in Thrombosis and Haemostasis|June 5, 2023
Evaluation of four commercial ELISAs to measure tissue factor in human plasmaAna T A Sachetto, Sierra J Archibald, Ravi Bhatia, et al.
Plos One|July 1, 2014
Soluble phosphatidylserine binds to two sites on human factor IXa in a Ca2+ dependent fashion to specifically regulate structure and activityRinku Majumder, Tilen Koklic, Tanusree Sengupta, et al.
Nature|September 6, 2002
RNA aptamers as reversible antagonists of coagulation factor IXaChristopher P Rusconi, Elizabeth Scardino, Juliana Layzer, et al.
Blood|April 24, 2016
Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B miceBrian Cooley, William Funkhouser, Dougald Monroe, et al.
Journal of Colloid and Interface Science|June 6, 2020
Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defectsSeema Nandi, Laura Sommerville, Kimberly Nellenbach, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood|June 20, 2020
EPCR knockout: inflaming the discussionDougald Monroe, Maureane Hoffman
Arteriosclerosis, Thrombosis, and Vascular Biology|November 20, 2009
What is wrong with the allosteric disulfide bond hypothesis?Ronald R Bach, Dougald Monroe
Arteriosclerosis, Thrombosis, and Vascular Biology|July 19, 2013
Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targetsMarshall Mazepa, Maureane Hoffman, Dougald Monroe
Blood|January 16, 2014
FVIIa as used pharmacologically is not TF dependent in hemophilia B miceDengmin Feng, Herbert Whinna, Dougald Monroe, et al.
Plos Computational Biology|November 15, 2024
A new look at TFPI inhibition of factor X activationFabian Santiago, Amandeep Kaur, Shannon Bride, et al.
Research and Practice in Thrombosis and Haemostasis|June 5, 2023
Evaluation of four commercial ELISAs to measure tissue factor in human plasmaAna T A Sachetto, Sierra J Archibald, Ravi Bhatia, et al.
Plos One|July 1, 2014
Soluble phosphatidylserine binds to two sites on human factor IXa in a Ca2+ dependent fashion to specifically regulate structure and activityRinku Majumder, Tilen Koklic, Tanusree Sengupta, et al.
Nature|September 6, 2002
RNA aptamers as reversible antagonists of coagulation factor IXaChristopher P Rusconi, Elizabeth Scardino, Juliana Layzer, et al.
Blood|April 24, 2016
Prophylactic efficacy of BeneFIX vs Alprolix in hemophilia B miceBrian Cooley, William Funkhouser, Dougald Monroe, et al.
Journal of Colloid and Interface Science|June 6, 2020
Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defectsSeema Nandi, Laura Sommerville, Kimberly Nellenbach, et al.
Pageof 2